Adenosine Therapeutics


Robert S. Capon, MBA - Chairman, CEO, and Co-founder

Robert S. Capon is a seasoned entrepreneur and CEO having been at the helm of four companies. Rob was one of three cofounders of ViroLogic, a pioneer in antiviral drug resistance testing, now a NASDAQ firm having completed an IPO (NASDAQ: MGRM). At Adenosine Therapeutics, Rob was the architect of the collaboration agreements with the University of Virginia Patent Foundation, Penn State University, Bristol Myers Squibb, Novartis and Santen.

Prior to founding Adenosine Therapeutics and ViroLogic, Rob founded HJC Software, the makers of Virex, the first commercial anti-virus software for the Macintosh personal computer. He came to Charlottesville in 1996 to take the helm as the CEO of MJ Systems, a 50-person software company, where he positioned the company for a successful exit. Rob is an adjunct faculty member at the University of Virginia?s Darden School, where he teaches Transactions and Dealmaking in the Life Sciences.

Rob serves as a member of the Piedmont Virginia Community College Educational Foundation. Rob has previously served as a member of the Advisory Board of the Governor Warner's Virginia Biotechnology Initiative as well as the board of the Virginia Research and Technology Advisory Commission (VRTAC), and VABio. He is a past board member of the NC Museum of Life and Science, the University of North Carolina's Moorehead Planetarium, AVIR sensors, Congregation Beth Israel, the University of Virginia Hillel Foundation, and the Virginia Discovery Museum, and was a past Fellow of the University of Virginia's Hereford Residential College.

Rob has an MBA with honors from the Harvard Business School, and a B.S. in Mechanical Engineering, with highest distinction, from the University of Virginia.

William S. Gray, Esq. - Executive Vice President, Secretary

William S. Gray, Esq. is an attorney with expertise in international and high technology commercial transactions. Mr. Gray joined the company in 2003 as Vice President of Licensing and Secretary having retired as a partner in the firm Williams Mullen.

Mr. Gray earned degrees from Harvard College and Harvard Law School and is a pastmember of the New York and Virginia bars. During his practice he concentrated on international and high technology commercial transactions for a number of successful high technology startups as well as major European industrial companies. Prior to entering private practice in Charlottesville, Mr. Gray was in-house counsel at General Electric Company for 17 years where he was involved in several of GE?s major merger and acquisition transactions. He also served during this time as counsel for the International Sales Division, Corporate Staff Counsel, Division Counsel of the GE Supply Company and Group Counsel of the Industrial Electronics (Factory Automation) Business Group.

Joseph Truluck, MA, MBA - VP, Operations & Finance

Joseph Truluck gained critical experience in operations and financial management at Adenosine Therapeutics prior to its acquisition by Clinical Data, Inc., where he assisted in many aspects of the business, from financial management to regulatory filings to due diligence prior to the buyout. After the purchase of ATL?s operations by Clinical Data, Mr. Truluck went on to gain an MBA from Tulane University with a concentration in Finance. After graduation, Mr. Truluck went on to co-found Beonten, Inc. in Boston with a team of experts in information economics. The business plan for Beonten was a Semi-Finalist in the prestigious MIT 100K business plan competition. Joe is the founder and current owner of Catallaxy Design, LLC, with which he is working on development of technologies applying information economics to real world problems.

In addition to his MBA at Tulane, Mr. Truluck earned an MA in Philosophy at the University of Virginia, with a thesis in the area of modal semantics.


Home | Corporate | Partnering | Contacts
2013 Adenosine Therapeutics, LLC. All rights reserved.